Literature DB >> 21475950

Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: a case and control study.

Angel F Remacha1, Joan Carles Souto2, José Luis Piñana2, María Pilar Sardà2, Josep Maria Queraltó3, Joan Martí-Fabregas4, Xavier García-Moll5, Cristina Férnandez6, Alvaro Rodriguez6, Jorge Cuesta6.   

Abstract

This study aimed at assessing the relationship between thrombosis, hyperhomocysteinemia and vitamin B12 deficiency using a case-control study carried out in 326 patients with thrombosis (case group) and 351 patients from the same hospital (control group). Apart from the classic risk factors, a number of hematological variables were evaluated, including serum vitamin B12 (B12), red cell folate (RCF), and serum homocysteine (Hcy). An evaluation of serum methylmalonic acid (MMA) and a clinical study were carried out to investigate B12 pathology. Results of univariate analysis demonstrated decreased B12 levels in thrombosis (Student's t test, p < 0.0001). Vitamin B12 below 200 pmol/l (LB200) or below 150 pmol/l (LB150), and red cell folate below 600 nmol/l were found in 17.2, 8.6, and 2.2% of cases with thromboembolism, respectively. An increase in Hcy was detected in 86 cases with thrombosis (26.3%). An abnormality in vitamin B12 and/or renal function was found in 80% of cases with hyperHcy and thrombosis. The MMA increase demonstrated that vitamin B12 deficiency was present in these patients with low levels of vitamin B12 in serum, and the MMA levels were in concordance with Hcy levels. The clinical study revealed B12 malabsorption in most cases with LB200. Multivariate analysis showed that serum vitamin B12 (RR 0.998, CI 0.997-0.999) was moderately related to thromboembolism. The results indicated that vitamin B12 deficiency was common among patients with hyperhomocysteinemia and thrombosis. Moreover, HyperHcy was caused by vitamin B12 deficiency and/or chronic renal failure in most patients with thrombosis. As the main cause of vitamin B12 deficiency was vitamin malabsorption, parenteral vitamin B12 with or without folic acid should be administered for the treatment of this condition. However, it remains to be demonstrated whether this treatment approach prevents recurrent thromboses in patients with vitamin B12 deficiency and thrombosis, as suggested by some case reports.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475950     DOI: 10.1007/s12185-011-0825-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  47 in total

1.  Fortification of flour with folic acid.

Authors:  B Wharton; I Booth
Journal:  BMJ       Date:  2001-11-24

2.  A case of unusual substance abuse causing myeloneuropathy.

Authors:  R M Shulman; T J Geraghty; M Tadros
Journal:  Spinal Cord       Date:  2006-08-08       Impact factor: 2.772

3.  Portal vein thrombosis due to hyperhomocysteinemia caused by vitamin B-12 deficiency.

Authors:  Mehmet Kanbay; Sema Karakus; Ugur Yilmaz
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

4.  Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period.

Authors:  Kelly F Wyckoff; Vijay Ganji
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

Review 5.  Metabolite assays in cobalamin and folate deficiency.

Authors:  R Green
Journal:  Baillieres Clin Haematol       Date:  1995-09

Review 6.  Are B vitamins a risk factor for VTE? Perhaps.

Authors:  M den Heijer
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

7.  Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.

Authors:  Joel G Ray; Clive Kearon; Qilong Yi; Patrick Sheridan; Eva Lonn
Journal:  Ann Intern Med       Date:  2007-04-30       Impact factor: 25.391

8.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

9.  Haematological effects of oral cobalamin preparations on patients with megaloblastic anaemia.

Authors:  H Kondo
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

10.  In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations.

Authors:  Jacob Selhub; Martha Savaria Morris; Paul F Jacques
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-04       Impact factor: 11.205

View more
  14 in total

Review 1.  Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies.

Authors:  Kuangguo Zhou; Ruizhi Zhao; Zhe Geng; Lijun Jiang; Yang Cao; Danmei Xu; Yin Liu; Liang Huang; Jianfeng Zhou
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

2.  Double venous compression due to duplicated inferior vena cava-induced right common iliac vein thrombosis.

Authors:  Yuichi Mukai; Shuhei Nozawa; Toshiro Suzuki
Journal:  BMJ Case Rep       Date:  2018-04-07

Review 3.  Worms, bacteria, and micronutrients: an elegant model of our diet.

Authors:  Lutfu Safak Yilmaz; Albertha J M Walhout
Journal:  Trends Genet       Date:  2014-08-26       Impact factor: 11.639

4.  Low nourishment of B-vitamins is associated with hyperhomocysteinemia and oxidative stress in newly diagnosed cardiac patients.

Authors:  Mostafa I Waly; Amanat Ali; Amira Al-Nassri; Mohamed Al-Mukhaini; John Valliatte; Yahya Al-Farsi
Journal:  Exp Biol Med (Maywood)       Date:  2015-08-04

5.  Portal, superior mesenteric and splenic vein thrombosis secondary to hyperhomocysteinemia with pernicious anemia: a case report.

Authors:  Prashanth Venkatesh; Nissar Shaikh; Mohammad F Malmstrom; Vajjala R Kumar; Bakr Nour
Journal:  J Med Case Rep       Date:  2014-08-25

6.  Correlation between secondary thrombosis in epileptic patients and serum levels of folate and vitamin B12.

Authors:  Hao Zhou; Hong-Li Huang; Nuan Wang; Xiao-Hu Pang
Journal:  Biomed Rep       Date:  2016-08-09

7.  Prevalence of hyperhomocysteinemia in healthy Indian doctors.

Authors:  Sandesh P Kamdi; Prashant Palkar
Journal:  Bioinformation       Date:  2013-02-21

8.  Does reactive thrombocytosis observed in iron deficiency anemia affect plasma viscosity?

Authors:  Selami K Toprak; Ibrahim Tek; Sema Karakuş; Nihat Gök; Nazmiye Kurşun
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

9.  Effects of antiepileptic drugs on the serum folate and vitamin B12 in various epileptic patients.

Authors:  Hong-Li Huang; Hao Zhou; Nuan Wang; Chun-Yu Yu
Journal:  Biomed Rep       Date:  2016-08-08

10.  Echinocystic acid ameliorates hyperhomocysteinemia-induced vascular endothelial cell injury through regulating NF-κB and CYP1A1.

Authors:  Chuan-Feng Huang; Wei-Na Wang; Cheng-Cao Sun; Yu-Qing Wang; Ling Li; Yin Li; De-Jia Li
Journal:  Exp Ther Med       Date:  2017-09-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.